221 related articles for article (PubMed ID: 22229791)
1. Targeting mitochondria for neuroprotection in Parkinson's disease.
Schapira AH
Antioxid Redox Signal; 2012 May; 16(9):965-73. PubMed ID: 22229791
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective therapy for Parkinson's disease.
Koller WC
Exp Neurol; 1997 Mar; 144(1):24-8. PubMed ID: 9126147
[TBL] [Abstract][Full Text] [Related]
3. Novel imine antioxidants at low nanomolar concentrations protect dopaminergic cells from oxidative neurotoxicity.
Hajieva P; Mocko JB; Moosmann B; Behl C
J Neurochem; 2009 Jul; 110(1):118-32. PubMed ID: 19486265
[TBL] [Abstract][Full Text] [Related]
4. Slowing of neurodegeneration in Parkinson's disease and Huntington's disease: future therapeutic perspectives.
Schapira AH; Olanow CW; Greenamyre JT; Bezard E
Lancet; 2014 Aug; 384(9942):545-55. PubMed ID: 24954676
[TBL] [Abstract][Full Text] [Related]
5. Polyhydroxylated fullerene derivative C(60)(OH)(24) prevents mitochondrial dysfunction and oxidative damage in an MPP(+) -induced cellular model of Parkinson's disease.
Cai X; Jia H; Liu Z; Hou B; Luo C; Feng Z; Li W; Liu J
J Neurosci Res; 2008 Dec; 86(16):3622-34. PubMed ID: 18709653
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial dynamics, cell death and the pathogenesis of Parkinson's disease.
Büeler H
Apoptosis; 2010 Nov; 15(11):1336-53. PubMed ID: 20131004
[TBL] [Abstract][Full Text] [Related]
7. α-Arbutin Protects Against Parkinson's Disease-Associated Mitochondrial Dysfunction In Vitro and In Vivo.
Ding Y; Kong D; Zhou T; Yang ND; Xin C; Xu J; Wang Q; Zhang H; Wu Q; Lu X; Lim K; Ma B; Zhang C; Li L; Huang W
Neuromolecular Med; 2020 Mar; 22(1):56-67. PubMed ID: 31401719
[TBL] [Abstract][Full Text] [Related]
8. Neuroprotection for Parkinson's disease.
LeWitt PA
J Neural Transm Suppl; 2006; (71):113-22. PubMed ID: 17447422
[TBL] [Abstract][Full Text] [Related]
9. Bioenergetic approaches for neuroprotection in Parkinson's disease.
Beal MF
Ann Neurol; 2003; 53 Suppl 3():S39-47; discussion S47-8. PubMed ID: 12666097
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic role of coenzyme Q(10) in Parkinson's disease.
Shults CW
Pharmacol Ther; 2005 Jul; 107(1):120-30. PubMed ID: 15963354
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria as a pharmacological target: magnum overview.
Olszewska A; Szewczyk A
IUBMB Life; 2013 Mar; 65(3):273-81. PubMed ID: 23441041
[TBL] [Abstract][Full Text] [Related]
12. Parkinson's disease, insulin resistance and novel agents of neuroprotection.
Aviles-Olmos I; Limousin P; Lees A; Foltynie T
Brain; 2013 Feb; 136(Pt 2):374-84. PubMed ID: 22344583
[TBL] [Abstract][Full Text] [Related]
13. [Neuroprotective effect of baicalein in patients with Parkinson's disease].
Yu X; He G; Du G
Zhongguo Zhong Yao Za Zhi; 2012 Feb; 37(4):421-5. PubMed ID: 22667137
[TBL] [Abstract][Full Text] [Related]
14. Melatonin protects against 6-OHDA-induced neurotoxicity in rats: a role for mitochondrial complex I activity.
Dabbeni-Sala F; Di Santo S ; Franceschini D; Skaper SD; Giusti P
FASEB J; 2001 Jan; 15(1):164-170. PubMed ID: 11149904
[TBL] [Abstract][Full Text] [Related]
15. Accumulation of mitochondrial DNA deletions within dopaminergic neurons triggers neuroprotective mechanisms.
Perier C; Bender A; García-Arumí E; Melià MJ; Bové J; Laub C; Klopstock T; Elstner M; Mounsey RB; Teismann P; Prolla T; Andreu AL; Vila M
Brain; 2013 Aug; 136(Pt 8):2369-78. PubMed ID: 23884809
[TBL] [Abstract][Full Text] [Related]
16. Neurotoxicity and neuroprotection in Parkinson's disease.
Lange KW; Youdim MB; Riederer P
J Neural Transm Suppl; 1992; 38():27-44. PubMed ID: 1491247
[TBL] [Abstract][Full Text] [Related]
17. Mitochondria and programmed cell death in Parkinson's disease: apoptosis and beyond.
Perier C; Bové J; Vila M
Antioxid Redox Signal; 2012 May; 16(9):883-95. PubMed ID: 21619488
[TBL] [Abstract][Full Text] [Related]
18. Mitochondria: A Therapeutic Target for Parkinson's Disease?
Luo Y; Hoffer A; Hoffer B; Qi X
Int J Mol Sci; 2015 Sep; 16(9):20704-30. PubMed ID: 26340618
[TBL] [Abstract][Full Text] [Related]
19. Mitochondria targeted therapeutic approaches in Parkinson's and Huntington's diseases.
Chaturvedi RK; Beal MF
Mol Cell Neurosci; 2013 Jul; 55():101-14. PubMed ID: 23220289
[TBL] [Abstract][Full Text] [Related]
20. Endoplasmic reticulum and mitochondria interplay mediates apoptotic cell death: relevance to Parkinson's disease.
Arduíno DM; Esteves AR; Cardoso SM; Oliveira CR
Neurochem Int; 2009 Sep; 55(5):341-8. PubMed ID: 19375464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
